Collectively, these investigations highlight the involvement of enhanced ADMA levels and redox imbalance in PCOS, suggesting variations in the activity of DDAH that may restrict NO levels by modulating ADMA 137. This evidence concerns the gene DDAH1 and polycystic ovary syndrome.